Get the latest Venture Capital & Angel investors news and info Join Our Mailing List:

Your Name: 

Your Email:  

*By submitting your name & email you agree to receive for FREE our scholarships & offers Newsletters. You agree also with the storage and handling of your data by this website and 3rd party email services.
You may unsubscribe if you wish. And you can delete your email and name at any time by emailing us to the email on the bottom of this page.

Follow us on
  • 3i Venture Capital

    3i joins as new investor in Sweden’s Carmel Pharma
    SLS Venture has signed an agreement to sell about 23 % of Carmel Pharma to 3i, Europe’s leading venture capital and private equity company.

    Demand Media Completes Over $100 Million in Funding
    The financing round was co-led by 3i and Oak Investment Partners, two leading venture capital and private equity firms. Spectrum Equity Investors also

    3i is a world leader in venture capital and private equity. The company invests in a wide range of opportunities from start-ups to buy-outs and buy-ins. The company focuses on those opportunities with high growth potential and strong management. The company’s function is to add value, bringing the extra capital, connections and knowledge that will create successful independent businesses around the world. The businesses, in which the company invests in, span more than 25 industry sectors and over 150 of them have achieved stock market listings in the last ten years. Just recently, 3i, announced that it has sold its 55% stake in Ezurio, a leading manufacturer of Bluetooth solutions, in a $25m transaction to Laird Technologies, Inc., a global leader in the design and supply of critical components for advanced electronics and wireless products. The successful sale of Ezurio sees 3i make a return of around three times money multiple on its investment in the company.


By using this website you agree with our cookie policy